Cornercap Investment Counsel Inc Viatris Inc Transaction History

Cornercap Investment Counsel Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 11, 2023	SELL	$9.2 - $12.26 $51,703 - $68,901	-5,620 Reduced 3.77%	143,292 $1.38 Million
Q4 2022 Feb 13, 2023	BUY	$8.72 - $11.56 $52,982 - $70,238	6,076 Added 4.25%	148,912 $1.66 Million
Q3 2022 Nov 14, 2022	BUY	$8.48 - $11.13 $47,928 - $62,906	5,652 Added 4.12%	142,836 $1.22 Million
Q2 2022 Aug 15, 2022	BUY	$9.95 - $12.27 $1.36 Million - $1.68 Million	137,184 New	137,184 $1.44 Million
Q3 2021 Nov 15, 2021	SELL	$13.25 - $15.13 $1.14 Million - $1.3 Million	-85,734 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$12.97 - $16.15 $68,390 - $85,158	-5,273 Reduced 5.79%	85,734 $1.23 Million
Q1 2021 May 13, 2021	BUY	$13.59 - $18.54 $1.24 Million - $1.69 Million	91,007 New	91,007 $1.27 Million

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15.2B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

Stay updated on Cornercap Investment Counsel Inc with notifications on news.